INTERVAL AFTER PROSTATE SPECIFIC ANTIGEN TESTING AND SUBSEQUENT RISK OF INCURABLE PROSTATE CANCER
- 1 September 2001
- journal article
- Published by Wolters Kluwer Health in Journal of Urology
- Vol. 166 (3) , 861-865
- https://doi.org/10.1016/s0022-5347(05)65852-1
Abstract
No abstract availableKeywords
This publication has 15 references indexed in Scilit:
- Cancer statistics, 2000CA: A Cancer Journal for Clinicians, 2000
- Why Don't Physicians Follow Clinical Practice Guidelines?JAMA, 1999
- Prostate Cancer Screening and Beliefs about Treatment Efficacy: A National Survey of Primary Care Physicians and UrologistsThe American Journal of Medicine, 1998
- Determinants of cancer screening frequency: the example of screening for cervical cancer.The Journal of the American Board of Family Medicine, 1998
- The European Randomized Study of Screening for Prostate Cancer (ERSPC)British Journal of Urology, 1997
- Prospective Evaluation Plan for Randomised Trials of Prostate Cancer ScreeningJournal of Medical Screening, 1996
- Prostate-specific antigen variability in men without prostate cancer: effect of sampling interval on prostate-specific antigen velocityUrology, 1995
- A prospective evaluation of plasma prostate-specific antigen for detection of prostatic cancerPublished by American Medical Association (AMA) ,1995
- Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial of the National Cancer InstituteJournal of Urology, 1994
- Standardized rates of recurrent outcomesStatistics in Medicine, 1994